These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1106217)

  • 1. A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients.
    Small JG; Kellams JJ; Milstein V; Moore J
    Am J Psychiatry; 1975 Dec; 132(12):1315-7. PubMed ID: 1106217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium combined with neuroleptics in the treatment of chronic schizophrenia.
    Kellams JJ; Small JG; Milstein V; Perex HC
    Psychopharmacol Bull; 1976 Apr; 12(2):27-30. PubMed ID: 769024
    [No Abstract]   [Full Text] [Related]  

  • 3. Lithium combined with neuroleptics in chronic schizophrenic and schizoaffective patients.
    Carman JS; Bigelow LB; Wyatt RJ
    J Clin Psychiatry; 1981 Mar; 42(3):124-8. PubMed ID: 6110654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic effects of lithium in schizophrenia.
    Alexander PE; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 Mar; 136(3):283-7. PubMed ID: 369396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 6. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 7. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
    Jus A; Villeneuve A; Gautier J; Jus K; Villeneuve C; Pires P; Villeneuve R
    Neuropsychobiology; 1978; 4(3):140-9. PubMed ID: 340975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of chronic schizophrenic females to a combination of diphenylhydantoin and neuroleptics: a double-blind study.
    Pinto A; Simopoulos AM; Uhlenhuth EH; DeRosa ER
    Compr Psychiatry; 1975; 16(6):529-36. PubMed ID: 1104252
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot study of pimozide in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
    [No Abstract]   [Full Text] [Related]  

  • 10. Lithium in schizo-affective disorders.
    Dinsmore PR; Ryback R
    Dis Nerv Syst; 1972 Dec; 33(12):771-6. PubMed ID: 4668969
    [No Abstract]   [Full Text] [Related]  

  • 11. Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review.
    Tobias LL; MacDonald ML
    Psychol Bull; 1974 Feb; 81(2):107-25. PubMed ID: 4149623
    [No Abstract]   [Full Text] [Related]  

  • 12. On the usefulness of the placebo and of the double-blind technique in the evaluation of psychotropic drugs.
    Tétreault L; Bordeleau JM
    Psychopharmacol Bull; 1971 Jul; 7(3):44-64. PubMed ID: 4940648
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is the long term care of schizophrenic patients necessary?].
    Müller P
    Nervenarzt; 1971 Aug; 42(8):393-6. PubMed ID: 4327592
    [No Abstract]   [Full Text] [Related]  

  • 14. Pimozide: a comparative study in the treatment of chronic schizophrenic patients.
    Pinard G; Prénoveau Y; Fliesen W; Elie R; Bielmann P; Lamontagne Y; Tétreault L
    Int J Clin Pharmacol; 1972 Apr; 6(1):22-7. PubMed ID: 4558783
    [No Abstract]   [Full Text] [Related]  

  • 15. Lithium combined with haloperidol in schizophrenic patients.
    Lerner Y; Mintzer Y; Schestatzky M
    Br J Psychiatry; 1988 Sep; 153():359-62. PubMed ID: 3150693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium augmentation fails to reduce symptoms in poorly responsive schizophrenic outpatients.
    Schulz SC; Thompson PA; Jacobs M; Ninan PT; Robinson D; Weiden PJ; Yadalam K; Glick ID; Odbert CL
    J Clin Psychiatry; 1999 Jun; 60(6):366-72. PubMed ID: 10401914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baclofen treatment in chronic schizophrenia: a clinical trial.
    Bigelow LB; Nasrallah H; Carman J; Gillin JC; Wyatt RJ
    Am J Psychiatry; 1977 Mar; 134(3):318-20. PubMed ID: 320885
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.
    Gerlach J; Thorsen K; Munkvad I
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):51-6. PubMed ID: 788002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium in schizophrenia.
    Taheri A
    Am J Psychiatry; 1976 Oct; 133(10):1208. PubMed ID: 970498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.